|
$6,495.00
By: , Published: Apr-2013
Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency rooms every year with symptoms such as chest pain, and these patients are typically assessed with in vitro d.....
|
|
|
$4,450.00
By: , Published: Apr-2013
Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency rooms every year with symptoms such as chest pain, and these patients are typically assessed with in vitro d.....
|
|
|
$4,450.00
By: , Published: Apr-2013
Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency rooms every year with symptoms such as chest pain, and these patients are typically assessed with in vitro d.....
|
|
|
$4,450.00
By: , Published: Apr-2013
Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency rooms every year with symptoms such as chest pain, and these patients are typically assessed with in vitro d.....
|
|
|
$4,450.00
By: , Published: Apr-2013
Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency rooms every year with symptoms such as chest pain, and these patients are typically assessed with in vitro d.....
|
|
|
$3,500.00
By: , Published: Apr-2013
Acute coronary syndrome (ACS) consists of two major diseases: myocardial infarction (MI) and unstable angina, with the former being one of the major killers in the mature markets. Though the incidence of ACS is either in decline or steady across the US and European countries, millions of ACS and suspected ACS patients still visit emergency rooms every year with symptoms such as chest pain, and these patients are typically assessed with in vitro d.....
|
|
|
$6,495.00
By: , Published: Feb-2013
Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in t.....
|
|
|
$4,450.00
By: , Published: Feb-2013
Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in th.....
|
|
|
$4,450.00
By: , Published: Feb-2013
Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in th.....
|
|
|
$4,450.00
By: , Published: Feb-2013
Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in th.....
|
|
|
$4,450.00
By: , Published: Feb-2013
Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Predictive breast cancer gene tests can be used to identify women who are at increased risk of developing hereditary breast cancer. The Predictive Breast Cancer Gene Testing market has seen exponential growth in th.....
|
|
|
$3,500.00
By: , Published: Feb-2013
Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence of breast cancer is increasing due to the increased life span and increasing adoption of Western lifestyle risk factors. Improved surveillance in developing countries has allowed the identification of more women with breast cancer in these regions. Early diagnosis of breast cancer is essential for a good prognosis, making diagnosis a.....
|
|
|
$2,500.00
By: , Published: Jan-2013
GlobalData’s new report, “New Zealand In Vitro Diagnostics Market Outlook to 2018” provides key market data on the New Zealand In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within market categories – Clinical Chemistry, Haematology, Immuno Chemistry, Histology And Cytology, Infectious Immunology, Microbiology Culture and Genetic Testing. The report also provides company shares and distr.....
|
|
|
$3,500.00
By: , Published: Jan-2013
GlobalData’s new report, “Asia-Pacific In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the Asia-Pacific In Vitro Diagnostics market – Australia, China, India and Japan. The report provides value (USD million) data for all the market categories – Clinical Chemistry, Genetic Testing, H.....
|
|
|
$2,500.00
By: , Published: Jan-2013
GlobalData’s new report, “Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides value ($m) data for each segment and sub-segment within five market categories – Hepatitis Viruses, Retroviruses, Other Virology, Infectious Immunology Rapid Tests and Bacteriology. The report also provides company shares and distribution shares data for the overall Infectious Immunology market in each of the afor.....
|
|
|
$2,500.00
By: , Published: Jan-2013
”Turkey In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Turkey In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious I.....
|
|
|
$2,500.00
By: , Published: Jan-2013
”Norway In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Norway In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious I.....
|
|
|
$2,500.00
By: , Published: Jan-2013
”Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Chile In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Imm.....
|
|
|
$2,500.00
By: , Published: Jan-2013
”United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the United Arab Emirates In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Im.....
|
|
|
$2,500.00
By: , Published: Jan-2013
”Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Egypt In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Imm.....
|
|
|
$2,500.00
By: , Published: Jan-2013
”Finland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Finland In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious.....
|
|
|
$2,500.00
By: , Published: Dec-2012
GlobalData’s new report, “India In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the India In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories Clinical Chemistry, Genetic Testing, Haematology, Histolog.....
|
|
|
$2,500.00
By: , Published: Dec-2012
GlobalData’s new report, “China In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the China In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories Clinical Chemistry, Genetic Testing, Haematology, Histolog.....
|
|
|
$2,500.00
By: , Published: Dec-2012
GlobalData’s new report, “Canada In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the Canada In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories Clinical Chemistry, Genetic Testing, Haematology, Histol.....
|
|
|
$2,500.00
By: , Published: Dec-2012
GlobalData’s new report, “Argentina In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the Argentina In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories Clinical Chemistry, Genetic Testing, Haematology, .....
|
|